China-Biotics to Report Fiscal Year 2011 Second Quarter Financial Results on November 9

- Teleconference to Be Held on Tuesday, November 9, 2010 at 8 a.m. EST -

Oct 26, 2010, 08:00 ET from China-Biotics, Inc.

SHANGHAI, Oct. 26 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced it will host a conference call at 8:00 a.m. Eastern Standard Time / 9:00 p.m. Beijing Time on Tuesday, November 9, 2010, to discuss the fiscal year 2011 second quarter and six months financial results for the period ended September 30, 2010.

The telephone numbers for the conference call are (866) 383-7998 (U.S.) or (617) 597-5329 (International), passcode: 45985589.  A live web cast of the call will also be available on the investor relations section of the Company's website www.chn-biotics.com. To listen to the web cast, please visit the site at least 10 minutes early to register, download and install any necessary audio software.

The replay of the web cast will be archived on the website, and investors will be able to access the recording of the conference call until midnight EST on November 16, 2010 by calling (888) 286-8010 (U.S.) or (617) 801-6888 (International) and entering passcode: 21680945.

About China-Biotics

China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com.

Contact:


Travis Cai

Chief Financial Officer

China-Biotics, Inc.

traviscai@chn-biotics.com


Shiwei Yin/Kevin Theiss

Grayling

646-284-9474

shiwei.yin@grayling.com

kevin.theiss@grayling.com



SOURCE China-Biotics, Inc.



RELATED LINKS

http://www.chn-biotics.com